2004
DOI: 10.1097/00019052-200410000-00009
|View full text |Cite
|
Sign up to set email alerts
|

Non-systemic vasculitic neuropathy

Abstract: Non-systemic vasculitic neuropathy is one of many localized vasculitides, with involvement restricted to nerves and (possibly) muscles. Inclusion and exclusion criteria differ between reported cohorts. All require a nerve biopsy diagnostic of or suspicious for vasculitis and no extra-neuromuscular involvement. Patients typically present subacutely with a painful, multifocal/asymmetric, distal-predominant neuropathy. In the absence of clinical or laboratory evidence of systemic vasculitis or a condition predisp… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

2
36
0
4

Year Published

2006
2006
2023
2023

Publication Types

Select...
4
3
2

Relationship

0
9

Authors

Journals

citations
Cited by 65 publications
(42 citation statements)
references
References 83 publications
2
36
0
4
Order By: Relevance
“…Therefore, increased protein levels can be used as a supportive but not mandatory criterion for the diagnosis 13 . Increased CSF protein without pleocytosis is usually present in patients with peripheral neuropathy associated with chronic GHVD 6,15 . Of the published CSF analyses, there was no evidence of blood-brain barrier disruption with increased CFS protein from chronic myeloid leukemia patients studied during HSCT and chronic GVHD, but there is report of increased CSF protein secondary to CIDP after HSCT (Table 2) 6,7,10, 11,16 .…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Therefore, increased protein levels can be used as a supportive but not mandatory criterion for the diagnosis 13 . Increased CSF protein without pleocytosis is usually present in patients with peripheral neuropathy associated with chronic GHVD 6,15 . Of the published CSF analyses, there was no evidence of blood-brain barrier disruption with increased CFS protein from chronic myeloid leukemia patients studied during HSCT and chronic GVHD, but there is report of increased CSF protein secondary to CIDP after HSCT (Table 2) 6,7,10, 11,16 .…”
Section: Discussionmentioning
confidence: 99%
“…The nerve ischemia secondary to inflammatory processes could induce acute axonal asymmetrical degeneration within the fascicle, that can occurs in CIDP, but had not been described to date in CIDP by chronic GVHD after HSCT 15,18 .…”
mentioning
confidence: 99%
“…Damage to the blood-nerve-barrier is induced by pro-inflammatory cytokines, oxidative stress-derived molecules, or metallo-proteinases [7]. Altered expression and function of adhesion molecules or leukocytes (primary T-cell) and endothelial cell activation play a key role in the pathogenesis [8,9].…”
Section: Discussionmentioning
confidence: 99%
“…Most patients present with subacute onset, which progresses with a painful, multifocal, asymmetric, and predominantly distal weakness [4]. Although NSVN appears to have a better prognosis than systemic vasculitides after treatment, more than 30% of patients relapse, and 60% have residual pain [5].…”
Section: Introductionmentioning
confidence: 99%